Sorry, but this study was apparently withdrawn by the BMJ as being biassed and of inadequate quality. It is still showing in the LancetI saved this just to print off and hand to HCPs with a hopeful smile and a prescription for statins.
cholesterol
Abstract from bmjopen.bmj.com
Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review
Objective It is well known that total cholesterol becomes less of a risk factor or not at all for all-cause and cardiovascular (CV) mortality with increasing age, but as little is known as to whether low-density lipoprotein cholesterol (LDL-C), one component of total cholesterol, is associated with mortality in the elderly, we decided to investigate this issue.
Setting, participants and outcome measures We sought PubMed for cohort studies, where LDL-C had been investigated as a risk factor for all-cause and/or CV mortality in individuals ≥60 years from the general population.
Results We identified 19 cohort studies including 30 cohorts with a total of 68 094 elderly people, where all-cause mortality was recorded in 28 cohorts and CV mortality in 9 cohorts. Inverse association between all-cause mortality and LDL-C was seen in 16 cohorts (in 14 with statistical significance) representing 92% of the number of participants, where this association was recorded. In the rest, no association was found. In two cohorts, CV mortality was highest in the lowest LDL-C quartile and with statistical significance; in seven cohorts, no association was found.
Conclusions High LDL-C is inversely associated with mortality in most people over 60 years. This finding is inconsistent with the cholesterol hypothesis (ie, that cholesterol, particularly LDL-C, is inherently atherogenic). Since elderly people with high LDL-C live as long or longer than those with low LDL-C, our analysis provides reason to question the validity of the cholesterol hypothesis. Moreover, our study provides the rationale for a re-evaluation of guidelines recommending pharmacological reduction of LDL-C in the elderly as a component of cardiovascular disease prevention strategies.
I have seen such reports, and agree with both the points you make hereThere seems to be a growing amount of actual analysis of data from population studies which shows that elderly people with higher TC, LDL and HDL show lower all cause mortality compared with those with lower lipoprotein levels. There are also reports that over half the people attending cardiology clinics have lower than average cholesterol.
Having medical people urging me to try to achieve something which could actually reduce my lifespan whilst making me feel absolutely dreadful (from previous experience) is quite concerning.
Many studies in the US use the VA (Veteran Affairs Dept) hospitals and care homes for their studies. It is a fairly static, sedentary, and captive cohort that is already catered for by the institution. They are good sources of elderly participants, and a goodly supply of cardio patients.The latter study seems only to have been made only on men. Sigh. Half the population that other studies show respond differently to cholesterol just don't count.
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?